936
J. Zhao et al. / Inorganic Chemistry Communications 14 (2011) 934–936
delivery agent for boron neutron capture therapy of brain tumors, J. Med. Chem.
49 (2006) 5513–5523;
f. V.J. Reddy, M.M. Roforth, C. Tan, M.V.R. Reddy, Synthesis of functionalized
carboranes as potential anticancer and BNCT agents, Inorg. Chem. 46 (2007)
381–383;
was that the signal of the closo-carborane cage (δH 1.1–3.1 (br)) was
disappeared and replaced by two characteristic broad peaks of nido-
structure(δH −2.4 to −2.9 and −0.5 to 2.5). In addition, the peak
corresponding to the amine hydrochloric acid of the closo- structure
(δH 8.99) disappeared, which allowed the identification of the
degradation of closo-carborane derivative 3.
g. C.D.I. Meo, L. Panza, D. Capitani, L. Mannina, A. Banzato, M. Rondina, D. Renier, A.
Rosato, V. Crescenzi, Hyaluronan as carrier of carboranes for tumor targeting in
boron neutron capture therapy, Biomacromolecules 8 (2007) 552–559.
[2] a. D. Grafstein, J. Bobinski, J. Dvorak, H. Smith, N. Schwartz, M.S. Cohen, M.M. Fein,
III. Reactions of the carboranes, Inorg. Chem. 2 (1963) 1120–1125;
b. L.I. Zakharkin, V.S. Kirillova, Cleavage of o-carboranes to (3)-l,2-dicarbaunde-
carborates by amines, Russ. Chem. Bull. 24 (1975) 2484–2486.
Appendix A. Supplementary material
[3] A. Varadarajan, M.F. Hawthorne, Novel carboranyl amino acids and peptides:
reagents for antibody modification and subsequent neutron-capture studies,
Bioconjug. Chem. 2 (1991) 242–253.
Supplementary data to this article can be found online at
doi:10.1016/j.inoche.2011.03.035.
[4] a. J.G. Wilson, A.K.M. Anisuzzaman, F. Alam, A.H. Soloway, Development of
carborane synthons: synthesis and chemistry of (aminoalkyl)carboranes, Inorg.
Chem. 31 (1992) 1955–1958;
References
b. A.S. Batsanov, A.E. Goeta, J.A.K. Howard, A.K. Hughes, J.M. Malget, The synthesis
of closo- and nido-(aminoalkyl)dicarbaboranes: a re-examination of contra-
dictory literature reports, crystal structure of [7-{H3N(CH2)3}-7,8-C2B9H11]·-
NH2NH2, J. Chem. Soc. Dalton Trans. (2001) 1820–1826.
[1] a. J.F. Valliant, K.J. Guenther, A.S. King, P. Morel, P. Schaffer, O.O. Sogbein, K.A.
Stephenson, The medicinal chemistry of carboranes, Coord. Chem. Rev. 232
(2002) 173–230;
b. L. Ma, J. Hamdi, F. Wong, M.F. Hawthorne, Closomers of high boron content:
synthesis, characterization, and potential application as unimolecular nano-
particle delivery vehicles for boron neutron capture therapy, Inorg. Chem. 45
(2006) 278–285;
c. S. Ronchi, D. Prosperi, C. Thimon, C. Morin, L. Panza, Synthesis of mono- and
bisglucuronylated carboranes, Tetrahedron Asymmetr. 16 (2005) 39–44;
d. Z. Yinghuai, A.T. Peng, K. Carpenter, J.A. Maguire, N.S. Hosmane, M. Takagaki,
Substituted carborane-appended water-soluble single-wall carbon nanotubes:
new approach to boron neutron capture therapy drug delivery, J. Am. Chem. Soc.
127 (2005) 9875–9880;
[5] R.A. Wiesboeck, M.F. Hawthorne, Dicarbaundecaborane(13) and derivatives, J. Am.
Chem. Soc. 86 (1964) 1642–1643.
[6] a. J.J. Schaeck, S.B. Kahl, Rapid cage degradation of 1-formyl- and 1-alkyloxycar-
bonyl-substituted 1,2-dicarba-closo-dodecaboranes by water or methanol in
polar organic solvents, Inorg. Chem. 38 (1999) 204–206;
b. L.O. Kononov, A.V. Orlova, A.I. Zinin, B.G. Kimel, I.B. Sivaev, V.I. Bregadze,
Conjugates of polyhedral boron compounds with carbohydrates. 2. Unexpected
easy closo- to nido-transformation of a carborane–carbohydrate conjugate in
neutral aqueous solution, J. Organomet. Chem. 690 (2005) 2769–2774.
[7] Y. Zhu, H. Zhang, J.A. Maguire, N.S. Hosmane, Synthesis and crystal structure of 1,2-
e. Y. Byun, B.T.S. Thirumamagal, W. Yang, S. Eriksson, R.F. Barth, W. Tjarks,
Preparation and biological evaluation of10B-enriched 3-[5-{2-(2,3-Dihydroxy-
prop-1-yl)-o-carboran-1-yl} pentan-1-yl]thymidine (N5-2OH), a new boron
bis(phthalimidomethyl)-1,2-dicarba-closo-dodecaborane(12):
a precursor to
polyamines, Inorg. Chem. Commun. 4 (2001) 447–449.